18 US FDA approval since 1980,
and 4 biosimilar medicines
13EMA approval since 2001,
and 2 biosimilar medicines
31innovator products in various stages of clinical development
10products in
our portfolio of biosimilar medicines*
As of August 7, 2019 *Numbers shown are global numbers